TMEM11 and acute myeloid leukemia: DHRS7B-TMEM11 and PLXNB-BLRD1 transcripts are most abundant in the AML test group, whereas TRIM28-TRIM28 and SLC16A3-METRNL are equally expressed in the three AML groups (AML-test, 82 AML-AK, 43 AML-NK).